HIF-1α is a key molecule for the progression of EMT-mediated renal fibrosis
HIF-1α is a key molecule for the progression of EMT-mediated renal fibrosis
批准号:
15590854
负责人:
IWANO Masayuki
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Epithelial-mesenchymal transition(EMT) plays a central role in mediating tubulointerstitial fibrosis. In human biopsy samples, tubular epithelial cells(TECs) surrounding the fibrotic area expressed fibroblast specific protein 1(FSP1), although TECs positive for α smooth muscle actin were very rare. Therefore, it is essential to examine FSP1 expression in TECs for the detection of EMT in renal fibrosis. Previous studies have implicated that chronic hypoxia is the main contributor to the development and progression of tubulointerstitial fibrosis. In this study, we examined whether hypoxia could be a factor mediating EMT in vitro and in vivo. We established the method to detect EMT in vitro, using primary culture of TECs genetically marked by Cre-loxP system. TECs started to elongate after hypoxic exposure and became fibroblast-like cells morphologically at 5 days after hypoxia. Immunocytochemistry revealed that more than 40% of TECs expressed FSP1 at 5 days after hypoxia. The chief mediator of hypoxic response is hypoxia-inducible factor 1(HIF-1), and its oxygen-sensitive component HIF-1α which is promptly degraded by a kind of ubiquitin ligase, the von Hippel-Lindau tumor suppressor (VHL) in normoxia. To study more directly whether HIF-1α functions in renal fibrosis in vivo, we generated a mouse line with epithelium-targeted expression of VHL gene (constitutively active HIF-1), using Cre-loxP-mediated recombination. Tubulointerstitial fibrosis was induced by unilateral ureteral obstruction(UUO). Both obstructed and unobstructed kidneys were harvested for immunohistochemistry 8 days after UUO. FSP1 positive cell numbers increased significantly in unobstructed kidneys of VHL mutant mice compared with wild type mice. These results strongly suggest that HIF-1α activates tissue fibroblasts in renal fibrosis via the induction of epithelial-mesenchymal transition(EMT).
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgA nephropathy
成纤维细胞特异性蛋白 1 是 IgA 肾病患者肾脏存活的特异性预后标志物
DOI:
--
发表时间:
2005
期刊:
Kidney Int (In press)
影响因子:
--
作者:
[Nishitani Y, Iwano M et al.]
通讯作者:
Iwano M et al.
線維芽細胞を中心とした間質線維化の発症機構について
以成纤维细胞为中心的间质纤维化的发生机制
DOI:
--
发表时间:
2004
期刊:
関西実験動物研究会会報 25
影响因子:
--
作者:
[Yamazato M, Ohya Y, Nakamoto M, et al., 岩野正之]
通讯作者:
岩野正之
Iwano M, Neilson EG: "Mechanisms of tubulointerstitial fibrosis"Current Opinion in Nephrology and Hypertension. in press.
Iwano M,Neilson EG:“肾小管间质纤维化的机制”肾脏病学和高血压的当前观点。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
組織の線維化と筋線維芽細胞:起源とその運命
组织纤维化和肌成纤维细胞:起源和命运
DOI:
--
发表时间:
2004
期刊:
炎症と免疫 12(6)
影响因子:
--
作者:
[Sato Y, Shomura H, Maeda Y, Mine T, Une Y, Akasaka Y, Kondo M, Takahashi S, Shinohara T, Katagiri K, Sato M, Okada S, Matsui K, Yamada A, Yamana H, Itoh K, Todo S., Imanishi K, 岩野正之]
通讯作者:
岩野正之
DOI:
10.1038/ki.1991.63
发表时间:
1991-03-01
期刊:
KIDNEY INTERNATIONAL
影响因子:
19.6
作者:
[KUNCIO, GS, NEILSON, EG, HAVERTY, T]
通讯作者:
HAVERTY, T
Novel strategy for the treatment of active nephritis using secreted FSP1
-
批准号:24390216
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2012
-
负责人:IWANO Masayuki
-
依托单位:
Protective role of FSP1-positive podocytes in the glomerular injury
-
批准号:21591036
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:IWANO Masayuki
-
依托单位:
Role of podocyte expression of FSP1 in the progression of kidney disease
-
批准号:19590960
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:IWANO Masayuki
-
依托单位:
Inhibition of HIF-la activity is a novel strategy for the treatment of tubulointerstitial fibrosis
-
批准号:17590839
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2005
-
负责人:IWANO Masayuki
-
依托单位:
Involvement of FSP1 positive fibroblasts in the progression of human glomerulonephntis
-
批准号:12671043
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:2000
-
负责人:IWANO Masayuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
miR-30c-5p通过MTDH/HIF-1α/PKM2环形反馈抑制乳腺癌进展的作用及机制研究
-
批准号:JCZRLH202600025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIF-1α-FtL信号轴通过调控神经元铁稳态抑制NLRP3炎性小体活化在脑缺血再灌注损伤中的作用与机制研究
-
批准号:JCZRLH202600706
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIF-1α介导H3K18乳酸化调控石榴皮多酚改善痤疮皮脂代谢紊乱机制研究
-
批准号:2026JJ60632
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王云
-
依托单位:
基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
-
批准号:2026JJ80362
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周新
-
依托单位:
糖尿病肾病肾纤维化改善新机制:SIRT3/HIF-1α维持足细胞脂代谢抑制细胞焦亡
-
批准号:2026JJ82303
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘润芝
-
依托单位:
降脂消斑片通过HIF-1α/PKM2信号通路介导的能量代谢重编程抑制巨噬细胞铁死亡治疗动脉粥样硬化的作用机制
-
批准号:2026JJ60305
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张杼惠
-
依托单位:
丹参酮IIA通过调控HIF-1α/AMPK-Nrf2信号轴缓解MSC氧化应激性衰老并促进骨生成的机制研究
-
批准号:JCZRLH202601107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
YTHDF2相分离调控HIF-1α内部核糖体进入位点依赖性翻译的机制研究
-
批准号:JCZRLH202600963
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于HIF-1αVEGFMMPs信号通路研究经筋弹拨法改善KOA大鼠骨破坏的研究
-
批准号:2026JJ80645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡金鲁
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位: